National Trends in Pulmonary Embolism Visit in United State Emergency Departments and Associated Costs (2006-2018)

Overview

Journal Emerg Med Int

Publisher Wiley

Date 2025 Jan 28

PMID 39872080

Authors

Ahmad Aalam

Diyaa Bokhary

Awad Alsabban

Ahmad Bakhribah

Affiliations

Soon will be listed here.

Abstract

Pulmonary embolism (PE) poses substantial morbidity and mortality risks, necessitating timely and accurate management in emergency departments (EDs). This study explores the trends in PE presentations to US EDs from 2006 to 2018 and assesses the impact of different factors on management and cost. This is a retrospective descriptive study conducted using the US Healthcare Cost and Utilization Project (HCUP) PE ED visits database. Data on ED visits, dispositions, and related costs were collected and analyzed. From 2006 to 2018 there were more than 2 million PE ED visits in the US. There was an increase in visits per 100,000 persons from 42.17 in 2006-2008 to 64.27 in 2016-2018 ( value < 0.001). The proportion of uninsured patients declined from 5.07% to 4.70%, and the percentage of Medicaid-insured patients increased. There was a decrease in the admission rates from 92.47% to 75.97% in 2016-2018 ( value < 0.001). The mean cost per admitted patient increased from $32,794 to $47,344 in 2016-2018 ( value < 0.001). From 2006 to 2018, PE ED visits in the US increased with a noticeable decrease in admission rates and length of stay, likely secondary to advancement in diagnostic and therapeutic modalities like computed tomography pulmonary angiography and novel oral anticoagulants. However, the observed rising healthcare costs pose challenges to sustainable management. Further research studies are needed to address cost-effective strategies.

References

Neiman P, Tsai T, Bergmark R, Ibrahim A, Nathan H, Scott J . The Affordable Care Act at 10 Years: Evaluating the Evidence and Navigating an Uncertain Future. J Surg Res. 2021; 263:102-109. DOI: 10.1016/j.jss.2020.12.056. View

Jareno Esteban J, de Miguel Diez J, Bermejo L . Pulmonary Embolism and Comorbidity. Open Respir Arch. 2023; 4(3):100188. PMC: 10369663. DOI: 10.1016/j.opresp.2022.100188. View

Raja A, Greenberg J, Qaseem A, Denberg T, Fitterman N, Schuur J . Evaluation of Patients With Suspected Acute Pulmonary Embolism: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med. 2015; 163(9):701-11. DOI: 10.7326/M14-1772. View

Martin K, Molsberry R, Cuttica M, Desai K, Schimmel D, Khan S . Time Trends in Pulmonary Embolism Mortality Rates in the United States, 1999 to 2018. J Am Heart Assoc. 2020; 9(17):e016784. PMC: 7660782. DOI: 10.1161/JAHA.120.016784. View

Konstantinides S, Meyer G . Management of acute pulmonary embolism 2019: what is new in the updated European guidelines?. Intern Emerg Med. 2020; 15(6):957-966. PMC: 7467952. DOI: 10.1007/s11739-020-02340-0. View

Agnelli G, Buller H, Cohen A, Curto M, Gallus A, Johnson M . Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med. 2013; 369(9):799-808. DOI: 10.1056/NEJMoa1302507. View

Buller H, Prins M, Lensin A, Decousus H, Jacobson B, Minar E . Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med. 2012; 366(14):1287-97. DOI: 10.1056/NEJMoa1113572. View

de Miguel-Diez J, Albaladejo-Vicente R, Lopez-de-Andres A, Hernandez-Barrera V, Jimenez D, Monreal M . Changing Trends in Hospital Admissions for Pulmonary Embolism in Spain from 2001 to 2018. J Clin Med. 2020; 9(10). PMC: 7599502. DOI: 10.3390/jcm9103221. View

Tice C, Seigerman M, Fiorilli P, Pugliese S, Khandhar S, Giri J . Management of Acute Pulmonary Embolism. Curr Cardiovasc Risk Rep. 2020; 14(12):24. PMC: 7538277. DOI: 10.1007/s12170-020-00659-z. View

10.

Konstantinides S, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galie N . 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014; 35(43):3033-69, 3069a-3069k. DOI: 10.1093/eurheartj/ehu283. View

11.

Erythropoulou-Kaltsidou A, Alkagiet S, Tziomalos K . New guidelines for the diagnosis and management of pulmonary embolism: Key changes. World J Cardiol. 2020; 12(5):161-166. PMC: 7284001. DOI: 10.4330/wjc.v12.i5.161. View

12.

Kort D, van Rein N, van der Meer F, Vermaas H, Wiersma N, Cannegieter S . Relationship between neighborhood socioeconomic status and venous thromboembolism: results from a population-based study. J Thromb Haemost. 2017; 15(12):2352-2360. DOI: 10.1111/jth.13868. View

13.

Fernandez M, Hogue S, Preblick R, Kwong W . Review of the cost of venous thromboembolism. Clinicoecon Outcomes Res. 2015; 7:451-62. PMC: 4559246. DOI: 10.2147/CEOR.S85635. View

14.

Feng L, Pines J, Yusuf H, Grosse S . U.S. trends in computed tomography use and diagnoses in emergency department visits by patients with symptoms suggestive of pulmonary embolism, 2001-2009. Acad Emerg Med. 2013; 20(10):1033-40. PMC: 4453868. DOI: 10.1111/acem.12221. View

15.

Singer A, Thode Jr H, Pines J . US Emergency Department Visits and Hospital Discharges Among Uninsured Patients Before and After Implementation of the Affordable Care Act. JAMA Netw Open. 2019; 2(4):e192662. PMC: 6481443. DOI: 10.1001/jamanetworkopen.2019.2662. View

16.

Konstantinides S, Meyer G, Becattini C, Bueno H, Geersing G, Harjola V . 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European.... Eur Respir J. 2019; 54(3). DOI: 10.1183/13993003.01647-2019. View

17.

Kline J, Courtney D, Kabrhel C, Moore C, Smithline H, Plewa M . Prospective multicenter evaluation of the pulmonary embolism rule-out criteria. J Thromb Haemost. 2008; 6(5):772-80. DOI: 10.1111/j.1538-7836.2008.02944.x. View